Ethimedix SA

What Ethimedix SA does

Ethimedix SA is a Switzerland-incorporated, privately-held medical device company founded in 2010 that has developed the SmartBottle, a programmable, biometrically-authenticated delivery device for oral liquid opioid medications. The platform is offered in two variants: the SmartBottle Team (SBP1000) for healthcare professionals managing multiple patients, and the SmartBottle Solo (SBP2000) for individual patient use at home or in hospital. Core technical features include fingerprint-based access control, a patented flash neutralization system that chemically deactivates the opioid if the device is tampered with, programmable dose volumes (5-15 mL) and lockout intervals, usage logging, and a non-rechargeable battery rated for approximately 4,000 doses over two years.

The product is CE marked as a Class I medical device (with Type BF applied part and IP31 ratings) and has been deployed at APHP Bicêtre Hospital in Paris for over 18 months across neurosurgery, urology, and orthopedics departments, where it has been used by more than 50 medical staff. In 2016 the device won the PharmaPack Europe Innovation Award for Best Healthcare Product, and in October 2018 Ethimedix submitted the technology to the FDA Innovation Challenge targeting opioid use disorder.

Ethimedix monetizes through direct sale of the SmartBottle hardware to hospitals, pain management clinics, and home-care patients, with quote-based institutional pricing. Go-to-market is enterprise field sales supplemented by heavy conference presence (SFAR, SSAR, AFARCOT, World Institute of Pain, Health + Care, PharmaPack Europe) targeting anesthesiologists, pain specialists, and hospital procurement teams. The company has no disclosed external funding, no reported revenue, and operations are anchored in France (Archamps subsidiary) with a US market entry pathway under development.

Name

Ethimedix SA

Legal name

Ethimedix SA

Website

https://ethimedix.com

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

1–10 employees

Short description

Ethimedix SA is a Swiss private medical device company (founded 2010) that develops the SmartBottle, a programmable, biometrically-authenticated drug delivery device for oral opioids used by hospitals, pain clinics, and home-care patients.

Ownership category

akta.pro rank

Product category

Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Medication Adherence & Smart Drug Delivery (Connected Inhalers, Pens, Pill Dispensers) (HLACAPAH)

akta.pro secondary industries

Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF), Remote Adherence Monitoring & Smart Dispenser Services (HSABALAI)

Keywords

• Programmable drug delivery
• Patient-controlled analgesia
• Biometric medical devices
• Opioid dispensing systems
• Oral medication administration

Headquarters

HQ city

Geneva

HQ country

Switzerland

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Others

Revenue model

1. SmartBottle Device Sales: Sale of SmartBottle hardware devices (SBP1000 TEAM and SBP2000 SOLO models) to hospitals, healthcare facilities, and for home use. The company develops and supplies medical devices for programmable drug delivery.
2. Enterprise/Institutional Sales: Direct sales to hospital groups and healthcare institutions. Tested extensively at APHP Bicêtre Hospital in Paris. Pricing likely involves institutional procurement processes.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Ethimedix SA develops and supplies the SmartBottle, a programmable medical device for controlled and secure oral administration of liquid medication, particularly opioid-based painkillers. The device integrates biometric fingerprint authentication, patented tamper-proof flash neutralization, programmable dosing schedules (5–15 mL per dose), and traceability data logging. It is offered in two variants — SmartBottle Solo (SBP2000) for individual patient use and SmartBottle Team (SBP1000) for healthcare professionals managing multiple patients — for post-operative, chronic, and palliative pain management in hospital and home settings.

Product overview

Ethimedix SA develops and provides the SmartBottle product line - a family of programmable, controllable drug delivery medical devices for oral liquid medication administration. The portfolio consists of two product variants: SmartBottle Solo (SBP2000) for individual patient use with biometric patient authentication, and SmartBottle Team (SBP1000) for healthcare professionals managing multiple patients. Both variants feature biometric fingerprint authentication, tamper-proof flash neutralization technology, programmable dosing (5-15mL per dose), and traceability data logging. The devices are designed for pain management applications including post-operative, chronic, and palliative care, usable in both hospital and home settings.

Differentiator

Problem solved

Functional benefit

Products and services

• SmartBottle A programmable medical device for controlled, secure oral administration of liquid medication, particularly opioid-based painkillers. Features biometric authentication, tamper-proof flash neutralization, and traceability logging for healthcare settings.
• SmartBottle Solo (SBP2000) Individual Patient-Controlled Analgesia device for home or hospital use with biometric fingerprint reader for patient authentication, programmable dosing (5–15 mL per dose), lockout periods between doses, and up to one month treatment capacity (1 L reservoir). Suited for post-operative, chronic, or palliative pain management.
• SmartBottle Team (SBP1000) Multi-patient version designed for healthcare professionals, allowing biometrically authenticated caregivers to deliver adjustable doses to multiple patients. Can be placed on treatment carts for efficient patient rounds and supports up to 20 different authorized caregivers.

Quantifiable outcome

• Saves healthcare providers up to 1 hour per shift
• +3 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• APHP Bicêtre Hospital (Hôpitaux Universitaires Paris-Sud)coreStrategic or Co-development Partner · 16 October 2018Primary clinical testing partner for SmartBottle technology. Over 18 months of clinical use with 20+ devices deployed in neurosurgery, urology, and orthopedics departments. Dr. Isabelle Negre, head of Pain Centre, serves as clinical champion and reference customer.

Scale indicators5 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Avanos Medical: Medical device company focused on pain management and respiratory health, selling post-operative and chronic pain solutions to hospitals. Comparable as it addresses the same clinical pain management workflow that Ethimedix serves, though via different delivery modalities.
• Becton, Dickinson and Company (BD): Major medical device manufacturer with a leading portfolio of IV Patient-Controlled Analgesia pumps and medication management solutions used in hospitals. Comparable because it competes in the same hospital pain management and controlled drug delivery category, though BD operates at vastly broader scale and across many device categories.
• Smiths Medical (now ICU Medical): Legacy provider of portable and hospital PCA pumps for opioid delivery. Comparable because its PCA pump products directly overlap with SmartBottle's pain management use case, although Smiths delivers opioids intravenously rather than orally.
• ICU Medical: Manufacturer of IV infusion pumps including PCA systems and medication safety software for hospitals. Comparable as an established provider of controlled drug delivery hardware and analytics in inpatient settings that Ethimedix also targets with its SmartBottle Team.

Emerging players

• Dose Health: Connected smart pill dispenser and medication adherence platform targeted at consumers and care providers. Comparable as another connected oral drug delivery device, although it focuses on adherence reminders rather than tamper-proof opioid neutralization.
• Pillo Health: Voice-activated home medication management and dispensing robot for chronic conditions and elderly users. Comparable as a connected at-home drug dispenser with biometric/identity features, though aimed at polypharmacy adherence rather than opioid security.
• Hero Health: Smart home pill dispenser with adherence reminders and caregiver notifications for patients managing multiple medications. Comparable as a connected in-home oral medication dispenser, though Hero focuses on general adherence rather than tamper-proof opioid delivery.
• Curonix: Developer of peripheral nerve stimulation systems for chronic pain management. Comparable as an adjacent pain management device company addressing the same opioid-sparing clinical goal that drives SmartBottle adoption in pain centers.

Direct peers

• AdhereTech: Developer of smart, connected pill bottles that monitor medication adherence and transmit usage data. Comparable because it targets the same connected oral medication adherence niche with a smart bottle format, though its focus is broader (oral oncology, chronic disease) rather than opioid-specific neutralization.
• Medipense (RxPense): Maker of the RxPense connected medication dispenser with biometric authentication for seniors and chronic care patients. Comparable as a directly competing connected, biometrically-secured pill dispenser addressing similar patient safety and adherence problems.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/ethimedix-sa

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ethimedix SA